Introduction
The novel gene CACNA2D2 has recently been identified in the homozygous deletion region of chromosome 3p21.3 in human lung and breast cancers (Gao et al., 2000, Lerman and . It is characterized structurally as a new a2d2 auxiliary subunit of the voltage-activated calcium channel (VACC) protein complex. The CACNA2D2 gene spans an B140 kb genomic locus in the 3p21.3 region, consists of at least 40 exons, and is expressed as a 5.5-5.7 kb mRNA. The CACNA2D2 protein consists of 1146 amino acids with a predicted molecular mass of 130 kDa (Gao et al., 2000) . Three splicing variants of CACNA2D2 mRNA have been detected, which result in two protein isoforms with different N-terminals (Angeloni et al., 2000) . The CACNA2D2 protein shows a 56% amino-acid sequence homology to that of the a2d1 subunit of the VACC complexes and shares a similar secondary and tertiary structure with the CACNA2D1, as suggested by the analysis of hydrophobicity, potential glycosylation sites, and bridge-forming cysteines of the primary sequence (Angeloni et al., 2000) . The CACNA2D2 protein is highly expressed in normal lung tissue, but either absent or underexpressed in more than 50% of lung cancers (Gao et al., 2000) . Since cancer cells are deficient in CACNA2D2, it has been suggested that CACNA2D2 could be a tumor suppressor gene linking Ca 2+ signaling with the pathogenesis of lung cancer and other cancers (Gao et al., 2000) .
Growing evidence has demonstrated that Ca 2+ signaling regulates and controls diverse cellular processes such as cell fertilization, development, proliferation, learning and memory, contraction and secretion, and cell death (Berridge et al., 1998 (Berridge et al., , 2000 . The universality of calcium as an intracellular messenger depends on the enormous range of timing, spatial, and temporal signals it can create in the complicated cellular processes (Berridge et al., 1998 (Berridge et al., , 2000 . Alteration of the spatial and temporal balances of intracellular calcium by either environmental stimuli or calcium effectors can result in cell death by both necrosis and apoptosis (Lemasters et al., 1998; Berridge et al., 2000; Zhu et al., 2000) . Early loss of CACNA2D2 expression in the pathogenesis of lung cancer (Angeloni et al., 2000) , inactivation of expression of other calcium channel-related proteins such as calcium/calmodulin-dependent deathassociated protein kinase (DAPK) (Raveh and Kimchi, 2001 ) and CACNA1G by promoter hypermethylation in various human cancers (Toyota et al., 1999; Ueki et al., 2000; Zochbauer-Muller et al., 2001) , and the growing role of Ca 2+ signaling in cell regulation (Berridge et al., 2000) , and especially its involvement in the mitochondria-mediated apoptotic pathway (Rutter and Rizzuto, 2000; Zhu et al., 2000) , motivated us to further investigate the function of the calcium channel protein CACNA2D2 in the regulation of cell proliferation and cell death and in the pathogenesis of human cancers. This study encompasses the effect of the ectopic expression of CACNA2D2 on mitochondria homeostasis, cell proliferation, apoptosis, and intracellular Ca 2+ contents by adenoviral vector-mediated wild-type (wt)-CACNA2D2 gene transfer in various 3p21.3-deficient NSCLC cell lines. We demonstrated that CACNA2D2-induced apoptosis was mediated through a cellular process involved in the regulation of the intracellular Ca 2+ contents, the disruption of mitochondria membrane integrity, the release of cyt c, and the activation of downstream caspases.
Results

Exogenous expression of CACNA2D2 inhibits tumor cell growth
To evaluate whether the CACNA2D2 could function as a tumor suppressor or a cell death mediator by inhibition of tumor cell growth in lung cancer, we performed a series of experiments to study the effect of ectopic expression of the CACNA2D2 gene on cell proliferation in various Ad-CACNA2D2-transduced human NSCLC cell lines NCI-H1299, NCI-H460, NCI-H358, and A549, with varying status of 3p21.3 markers (Figure 1 ). Cells from each line were transduced in vitro by the Ad-CACNA2D2 vector administered at various MOIs, and cells treated with PBS, the empty vector Ad-EV, Ad-LacZ, or Ad-GFP were used as controls. The transduction efficiency was determined by examining the GFP-expressing cells in the Ad-GFP transduced cell population under a fluorescence microscope. The transduction efficiency of the adenoviral vectors was greater than 80% at the highest MOI applied for each cell line. Expression of CACNA2D2 was verified by RT-PCR analysis ( Figure 1a ) and Western blot analysis (Figure 1b) , respectively, in Ad-CACNA2D2-transduced NSCLC cells. The transfection by plasmid DNA and the transduction by adenoviral vector are less efficient in A549, H460, and H358 cells than those in H1299 cells. Although the transcription of CACNA2D2 could be detected by RT-PCR (Figure 1a) , the protein expression could only be detected at a trace amount by Western blot analysis (Figure 1b) in the CACNA2D2-containing plasmid DNA-transfected A459, H460, and H358 cells. A significantly elevated expression of CACNA2D2 proteins could be detected in all cell lines transduced by the Ad-CACN vector ( Figure 1b) .
We analysed cell proliferation by determining the viability of cells at 2 and 5 days post-transduction, respectively. Tumor cell growth was significantly inhibited in all the cell lines transduced by the Ad-CACNA2D2 vector 5 days after transduction, compared with what we observed with untreated cells (PBS) or those treated with Ad-EV and Ad-LacZ controls ( Figure 1c ). The A549 cell line appeared to be the most sensitive to the ectopic expression of CACNA2D2 and showed a more than 60% reduction in cell viability at day 5 (Figure 1c, A549) , while moderate reduction of cell viability was observed in Ad-CACNA2D2-transduced H358 (44%), H460 (42%), and H1299 (28%) cells (Figure 1c ). Adp53 was used as a positive control and was less effective than Ad-CACNA2D2 in A549 and H460, which contain wt-p53. No significant effect on cell viability was observed in controls treated with PBS, AdEV, and Ad-LacZ.
The effect of enforced expression of the wt-CAC-NA2D2 gene on tumor growth was further evaluated in vivo by direct intratumoral injection of Ad-CACNA2D2 vector, along with PBS and Ad-LacZ vector as controls, into human NSCLC H460 tumor xenografts in nu/nu mice ( Figure 1d ). The growth of tumors was recorded from the first injection until about 20 days after the last injection. Tumor volumes were normalized by calculat- 
Induction of apoptosis by exogenous expression of CACNA2D2
One of the physiological functions associated with calcium channel proteins is their ability to induce apoptosis by regulating intracellular Ca +2 signaling and several downstream pathways (Lam et al., 1994; Walker and De Waard, 1998; Felix, 1999; Wang et al., 1999a; Zhu et al., 1999 Zhu et al., , 2000 . To test whether the growth inhibition by the ectopic expression of CAC-NA2D2 was caused by induction of apoptosis, we performed FACS analysis with TUNEL reaction and PI staining to examine DNA fragmentation and cell cycle kinetics in Ad-CACNA2D2-transduced cells (Figure 2 ). Significant induction of apoptosis was observed in Ad-CACNA2D2-transduced A549 (50.1%) (Figure 2a respectively), but with a less degree of correlation in H1299 cells which are less sensitive to exogenous expression of CACNA2D2, suggesting that the growth inhibition by the ectopic expression of CACNA2D2 might be mediated by the induction of apoptosis. We saw no significant alteration in cell cycle kinetics, such as G1 arrest or G2/M arrest, in these Ad-CACNA2D2-transduced cells (data not shown).
Upregulation of intracellular free cytosolic Ca 2+
CACNA2D2 is structurally related to the a2d2 subunit of the VACC protein complex, which has been suggested to regulate Ca +2 trafficking through the channel and the retention of VACC at the plasma membrane without significant change in such properties as channel gating or permeation (Wang et al., 1999b; Marais et al., 2001) . To examine whether the ectopic overexpression of this CACNA2D2 subunit would increase free cytosolic Ca 2+ influx, we measured changes in the levels of intracellular Ca 2+ in Ad-CACNA2D2-transduced cells by a sensitive FACS and fluorescence image analysis with fluorescent Fluo3-AM staining (Kao et al., 1989) . Fluo3-AM dye binds specifically to free Ca 2+ and shows an increase of emission fluorescence at 530 nm upon excitation at 488 nm. The fluorescence intensity depends on how much free Ca was also detected, but exhibited a lower magnitude and a slower manifestation (the peak emission was registered 72-96 h post-treatment) than that in Ad-CACNA2D2-transduced cells (the peak emission was registered 48 h post-treatment). The increase of free cytosolic Ca 2+ occurred shortly prior to apoptosis in these Ad-CACNA2D2-treated cells, suggesting a possible association of the induction of apoptosis by CACNA2D2 activity and the regulation of intracellular Ca 2+ signaling, homeostasis, or both. However, this experimental setting does not allow to link mechanistically the Ca 2+ increase to the apoptotic induction. The Fluo3-AM loading and staining conditions were optimized and confirmed by treating cell samples with 2 mg of ionomycin (a ionophore) (Kochegarov et al., 2001 ) as a positive control, which showed uniform fluorescence emission increase in all treated cells (Figure 3a , panels d and e).
Interruption of mitochondria membrane potential
Depolarization of mitochondria and loss of mitochondria membrane potential can be a rate-limiting step in apoptosis as well as in necrotic cell death Vieira et al., 2000) . The emerging evidence suggests that an excessive influx of Ca 2+ represents a prototypical example of a cell death stimulus where mitochondria membrane depolarization precedes cyt c release Vieira et al., 2000) . To investigate further the impact of the observed increase in intracellular free Ca 2+ influx by ectopic expression of CACNA2D2 on mitochondria membrane integrity, we analysed the changes of mitochondria membrane potential in Ad-CACNA2D2-transduced NSCLC cells by FACS with mitochondria membrane potential-specific fluorescent JC-1 staining (Figure 4 (Figure 5d ). The timing of the CACNA2D2-induced cyt c release was sequential and matched the timing of CACNA2D2-induced changes in intracellular Ca 2+ influx (Figure 3 ) and mitochondria membrane potential (Figures 4 and 5d) .
Activation of caspase 3 and PARP
Activation of caspases and PARP by translocation of cyt c from mitochondria to the cytosol is one of the protein complex (Angeloni et al., 2000; Gao et al., 2000) . Various VACC protein subunits such as the poreforming a1 unit and the auxiliary b, g, and a2d subunits have been identified and partially characterized (Singer et al., 1991; Castellano et al., 1993; Brown and Gee, 1998; Burgess et al., 1999; Felix, 1999 Varadi et al., 1999; Catterall, 2000; Lacinova et al., 2000) . The a2d2 subunit (CACNA2D2) of VACC is a regulatory subunit (Gao et al., 2000) . Mutation of this gene has been found to lead to a phenotype characterized by epilepsy, ataxia, and alterations of calcium currents in cerebellar cells in mice, which is ultimately fatal (Barclay et al., 2001) . Although the exact physiological function of CACNA2D2 in nonexcitable cells remains unknown, functional studies of CAC-NA2D2 have revealed that the activity of CACNA2D2 protein may alter the conductance properties of the pore-forming a1 unit as well as their membrane trafficking and, therefore dynamically regulates Ca The very frequent and early loss of expression of CACNA2D2 together with a subset of genes in the 3p21.3 homozygous deletion region of human chromosome 3 in human lung and breast cancers suggest a link between the CACNA2D2 and the regulation of proliferation and cell death in lung cancer pathogenesis, possibly through the regulation of the VACC-mediated Ca 2+ influx (Angeloni et al., 2000; Gao et al., 2000; Lerman and Minna, 2000) . However, no direct evidence has been presented for this link. In this study, we focused on CACNA2D2-mediated apoptosis by adenoviral vector-mediated ectopic expression of the wt-CACNA2D2 gene in the CACNA2D2-deficient NSCLC cells. We presented indirect evidence to link the CACNA2D2-mediated apoptosis with the regulation of the intracellular calcium content, interruption of mitochondria membrane integrity, and activation of downstream caspases.
Inhibition of tumor cell growth by ectopic expression of CACNA2D2 is concomitant with induction of apoptosis in these Ad-CACNA2D2-transduced NSCLC cells. A significant induction of apoptosis was observed 48 h after transduction. The cell lines most sensitive to CACNA2D2-induced apoptosis were A549 and H460, which contain a wt-p53 gene and are generally resistant to either the transduction of adenoviral vectors or to wtp53-mediated cell death. Ad-CACNA2D2-transduced H358 cells, which carry a mutated p53 gene, showed remarkable inhibition of cell growth but no significant induction of apoptosis. H1299 cells, which are p53-null, were the most resistant to CACNA2D2-induced growth inhibition and apoptosis in vitro and in vivo. These results suggest a possible association of the CAC-NA2D2-mediated apoptosis with the activities of wtp53, which is very interesting and needs to be explored further.
Based on the evidence that the activity of CAC-NA2D2 dynamically regulates Ca 2+ currents in L-and T-type calcium channels Gao et al., 2000; Hobom et al., 2000; Hurley et al., 2000) , we expected that overexpression of CACNA2D2 might result in an increase in the level of cytosolic Ca 2+ influx. A significant increase in the basal level of the intracellular free Ca 2+ was indeed detected in Ad-CACNA2D2-transduced H460 and A549 cells using (Berridge et al., 1998 (Berridge et al., , 2000 . Furthermore, Ca 2+ signals have a wide range of spatial and temporal distribution and so are capable of conveying signals in a very complex way (Lemasters et al., 1998; Berridge et al., 2000; Zhu et al., 2000) . Together, these factors make it difficult to detect even the global Ca 2+ oscillations in our experimental setting; therefore, our data may not represent the accurate dynamic changes of intracellular Ca 2+ contents and influx.
Mitochondria play a major role in apoptosis triggered by many stimuli. Disruption and permeation of the mitochondria membrane are general phenomena associated with the processes of apoptosis and necrotic cell death Reed, 2000, Vieira et al., 2000) . An excessive mitochondria Ca 2+ influx has been suggested to be a potent cell death stimulus leading to mitochondria membrane depolarization and cyt c release Vieira et al., 2000) . Activation of caspases by translocation of cyt c from mitochondria to the cytosol is a downstream event through which the mitochondrion's role as a regulator of cell life and death has become unquestioned (Chen et al., 2000; von Ahsen et al., 2000; Martinou and Green, 2001) . We demonstrated that ectopic expression of CACNA2D2 was associated with the accumulation of intracellular free Ca 2+ and the collapse of the mitochondria membrane potential prior to cyt c release and nuclear apoptotic changes, suggesting a physiological effect of CAC-NA2D2 activity in regulating cell survival by indirectly altering the mitochondria membrane integrity in concomitance with cytosolic Ca 2+ increase. Rupture of the outer membrane results in the release of many proteins such as cyt c and some caspases (Desagher and Martinou, 2000) . However, whether this is the result of a direct effect of the CACNA2D2-mediated Ca 2+ oscillations on mitochondria permeability needs to be further investigated. It would also be interesting to explore the CACNA2D2-mediated Ca 2+ -signaling pathways involved in activation of the proapoptotic mediators such as Bad and Bax and inactivation of the antiapoptotic factors such as Bcl-2 and Bclx that convey the apoptotic signal to the mitochondrion (Gross et al., 1999; Vieira et al., 2000; von Ahsen et al., 2000) .
Together, our results suggest that ectopic expression of CACNA2D2 is capable of inducing apoptosis in several NSCLC cell lines. The induction of apoptosis by CACNA2D2 activity is associated with the regulation of cytosolic Ca 2+ contents and the activation of the mitochondria pathway. Further identification of the physiological functions of CACNA2D2 in unexcitable cells such as normal bronchial epithelial cells, the evaluation of the cellular modulation of endogenous and exogenous expression of CACNA2D2 in response to environmental stimuli such as DNA-damaging agents and oncogene activities in normal and tumor cells, and the characterization of the effects of CACNA2D2 activity on both L-and T-type calcium channels in the presence and absence of selective inhibitors of the various VACC subtypes will provide us insight into the molecular mechanisms in the CACNA2D2-mediated regulation of cell proliferation and cell death in the pathogenesis of lung cancers and other human cancers.
Materials and methods
Cell lines and cell culture
Four human NSCLC cell lines, A549 (homozygous for multiple 3p21.3 markers and wt-p53), NCI-H1299 (homozygous for multiple 3p21.3 markers and homozygous deletion of p53), NCI-H358 (retained heterozygosity of multiple 3p21.3 markers and homozygous deletion of p53), and NCI-H460 (homozygous for multiple 3p21.3 markers and wt-p53), with varied 3p21.3 and p53 gene status, and a normal human bronchial epithelial cell line (HBEC) or fibroblast cells were used for in vitro experiments. The multiple 3p21.3 markers located in the 630 kb region used for this analysis were described previously (Fondon et al., 1998) . The A549 line was maintained in Ham's F12 medium supplemented with 10% fetal calf serum. The H1299, H358, and H460 lines were maintained in RPMI-1640 medium supplemented with 10% fetal calf serum and 5% glutamine.
Recombinant adenoviral vectors
The recombinant Ad-CACNA2D2 was constructed using our recently developed ligation-mediated plasmid adenovirus vector construction system, named herein pAd-RAP and pAd-RAP-Shuttle. The CACNA2D2 was assembled as a mammalian gene expression cassette that is driven by a CMV promoter and tailed with a bovine growth hormone (BGH) poly (A) signal sequence. Sequences of the CAC-NA2D2 gene in the viral vectors were confirmed by automated DNA sequencing. A vector expressing the GFP (green fluorescence protein) gene (Ad-GFP) and a vector carrying the b-galactosidase gene LacZ (Ad-LacZ) were used to monitor the efficiency of transduction by the viral vectors and as nonspecific transgene expression controls. Ad-EV, an empty E1-deleted vector, was used as a negative control; Adp53, a vector containing the wt-p53 gene, was used as a positive control for tumor suppression. Viral titers were determined by both optical density measurement (i.e. vp/ml) and plaque assay (i.e. plaque-forming units (PFU)/ml).
Animal experiments
All animals were maintained and animal experiments were performed under NIH and institutional guidelines established for the Animal Core Facility at the University of Texas MD Anderson Cancer Center. Procedures for H460 subcutaneous tumor inoculations in nu/nu mice were described previously (Ji et al., 1999) . When the average tumor size reaches about 0.5 cm in diameter, mice were injected intratumorally three times within a week with Ad-CACNA2D2 and control vectors at a dose of 3 Â 10 10 PFU (3 Â 10 12 vp)/tumor in a volume of 0.2 ml. Differences in tumor volumes between treatment groups were analysed with a mixed model ANOVA using the Statistica software (StatSoft Inc., Tulsa, OK, USA). A difference was considered to be statistically significant when P ¼ 0.05.
Analysis of CACNA2D2 gene Expression by RT-PCR
Total RNA samples were isolated from Ad-CACNA2D2-transduced tumor cells using TRIZOL reagent (Life Technologies, Grand Island, NY, USA) as instructed by the manufacturer. The RT reaction was performed using a reverse transcription kit with the oligo-d(T) 16 as a primer under the conditions recommended by the manufacturer (Perkin-Elmer Applied Biosystems, Foster City, CA, USA). The RT-PCR products amplified with human total RNA as a template and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) primers were used as an internal control. The primers for CACNA2D2 were 5 0 GACTGACCAACACCACTCTTCTC (sense, within CACNA2D2 cDNA) and 5 0 CTCATCGTACCTCAGCTCCTTCC (antisense, within the BGH poly (A) signaling region). The PCR was performed using an AmpliTaq PCR Kit and a 9600 PCR instrument according to the manufacturer's instructions (Perkin-Elmer Applied Biosystems).
Cell viability assay
Inhibition of tumor cell growth by treatment with Ad-CACNA2D2 and control vectors was analysed by quantitatively determining cell viability using an improved XTT assay (Roche Molecular Biochemicals, Indianapolis, IN, USA). Briefly, cells were plated in 96-well microtiter plates at 1 Â 10 3 cells/well in 100 ml of medium. One day after the cells were plated, a 100-ml aliquot of medium containing individual adenoviral vectors at various multiplicities of infection MOI in units of vp/cell (vp/c) was placed into each sample well, and phosphate-buffered saline (PBS), Ad-EV, Ad-LacZ, and Adp53 were added as controls. On designated sampling days after transduction, cell growth and viability were quantified by XTT assay as described previously (Nishizaki et al., 2001) . The percentage of cell viability was calculated in terms of the absorbency of treated cells relative to the absorbency of untreated control cells. Experiments were repeated at least three times with quadruplicate samples for each treatment in each individual experiment.
Analysis of apoptosis and cell cycle kinetics
Induction of apoptosis in tumor cells treated with various adenoviral vectors was analysed by flow cytometry (FACS) using terminal deoxynucleotidyl transferase-mediated dUTP nickend labeling (TUNEL) reaction with fluorescein (FITC)-labeled dUTP (Roche Molecular Biochemicals, Mannheim, Germany). Briefly, cells were plated in six-well plates (1 Â 10 6 cells/well) and treated by various Ad-CACNA2D2 vectors; PBS, Ad-EV, Ad-LacZ, and Adp53 were used as controls. At designated times after transduction, cells were harvested and washed in PBS. Cells were processed for FACS analysis to determine apoptosis and cell cycle kinetics as described previously (Ji et al., 1999) . , and 1% fetal bovine serum (FBS). The Fluo3-AM stock solution was prepared by first dissolving 50 mg of Fluo3-AM dye in 20 ml of DMSO containing 20% of the detergent Fluronic F-127 (Molecular Probes) and then mixing it with 117 ml of FBS. The cells were resuspended in 1 ml of HBSS containing the Fluo3-AM dye in a final concentration of 2.5-5.0 mg/ml, depending on the cell type. The anion carrier inhibitor probenecid was added at a final concentration of 4 mm to minimize the dye leakage. The cells were incubated for 45 min at room temperature on an orbital shaker in the dark. Cells were spun down by centrifugation for 5 min at 1500 r.p.m. and washed once with HBSS. Cells were gently resuspended in HBSS containing 4 mm of probenecid and then incubated for 20 min in the dark to allow cellular esterases to cleave the acetoxymethyl group of Fluo3-AM. Fluorescence intensity in the stained cells was measured by FACS analysis at an excitation wavelength of 488 nm and an emission wavelength of 530 nm. Experiments were performed three times independently. To evaluate the conditions of dye loading, 2 mg of ionomycin, an ionophoric antibiotic synthesized by Streptomyces conglobatus sp. (Calbiochem, Fremont, CA, USA), was added to each of the cell samples in a separate tube, and the dynamic fluorescence emission was measured by FACS after baseline fluorescence was assessed. For fluorescence imaging analysis of Fluo3-AM stained cells, the cells were cultured in chamber slides (Falcon), and then treated and stained with Fluo3-AM with the same procedure as was described for FACS analysis. The stained cells were examined under a microscope (Nikon Labophot 2) equipped with a digital camera (Nikon DMX1200, Tokyo, Japan) and the analysis software (Nikon ACT-1 V2.0).
Measurement of cytosolic free calcium
Analysis of mitochondria membrane potential by FACS with JC-1 staining
Changes in mitochondria membrane potential in adenoviral vector-transduced cells were measured by flow cytometry with JC-1 (5,5 0 ,6,6 0 -tetrachloro-1,1 0 3,3 0 -tetraethylbenzimidazolylcarbocyanine iodide) staining (Molecular Probes, Eugene, OR, USA). JC-1 exists as a monomer at low concentrations or at low membrane potential and emits green fluorescence at 527 nm. However, at higher concentrations or higher membrane potentials, JC-1 forms J-aggregates and emits maximum red fluorescence at B590 nm. The measurement of the ratio of the red to green JC-1 fluorescence in cells by flow cytometry is a sensitive and specific method for monitoring changes in mitochondria potential in living cells during induction of apoptosis by various agents (Ankarcrona et al., 1995; Cossarizza et al., 1995) . Cells were cultured in six-well plates and, after reaching B70% confluence, transduced with various adenoviral vectors at varied MOIs. Cells were collected by centrifugation for 5 min at 2000 r.p.m. at 41C and resuspended in complete medium containing 10 mg/ml JC-1 at a density of 5 Â 10 5 cells/ml. The cells were incubated for 10 min at room temperature in the dark, washed twice with cold PBS, resuspended in 400 ml of PBS, and analysed immediately by flow cytometry.
For in situ fluorescent staining with JC-1, cells were cultured in chamber slides. At designated time points, the medium was removed and the cells incubated in reduced serum Opti-MEM-I medium (GIBCO BRL, Grand Island, NY, USA) containing 10 mg/ml of JC-1 for 10 min in the dark. After washing and airdrying, stained cells were immediately examined by fluorescence microscopy.
Western blot analysis
Western blot analysis was performed to evaluate the expression of CACNA2D2 protein, the release of cyt c, activation of caspase 3 and PARP, and other protein expression in Ad-CACNA2D2 and control vector-transduced cells. For the preparation of crude cell lysates, cells were suspended in SDS-PAGE running buffer containing a complete set of proteinase inhibitors (Roche Molecular Biochemials, Mannheim, Germany) and lysed for 20 min at 41C. Cell lysates were passed through a 25-gauge needle and briefly sonicated twice for 30 s. For cyt c analysis, cell fractionation was performed to separate mitochondria-enriched fractions from cytosol fractions using an Apo-Alert Cell Fractionation Kit (ClonTech, Palo Alto, CA, USA) according to the manufacturer's instructions. Fractionated cell lysates were kept in equal volume in 2 Â lysis buffer supplemented with 62.5 mm urea. Protein concentrations were assayed using the Bio-Rad protein assay reagent (Bio-Rad Laboratories, Hercules, CA, USA). The crude cell lysates (about 50 mg) were used in standard SDS-PAGE and Western blot analysis.
Immunofluorescence staining
Immunofluorescence staining was performed in cells cultured in chamber slides. At designated time points, the cells were washed twice with cold PBS fixed in 4% paraformaldehyde for 15 min at 41C and made permeable by incubation for 5 min in a solution containing 0.1% Triton X-100 and 0.1% sodium citrate. The cells were incubated with the primary monoclonal mouse anti-cyt C antibody for 60 min at 371C, and after washing were incubated with the FITC-labeled secondary rabbit anti-mouse IgG antibodies for 60 min. After three washing steps in 0.1% Tween 20-PBS solution and air-drying, the slides were mounted with aqueous mounting medium containing 50 mg/ml of PI for nuclear staining and immediately examined under a fluorescence microscope.
Statistics
All the experiments were repeated at least two times with duplicates or triplicates of samples. The results were expressed as mean7s.d. Student's two-sided t-test was used to compare the values of the test and control samples. A value of Po0.05 was taken as significant.
Abbreviation:
ADP, adenosinediphosphate; CACNA2D2, calcium-channel alfa-2-delta-2 subunit; COX IV (I), cytochrome oxidase IV subunit I; cyt C, cytochrome C; DAPK, death-associated protein kinase; DMSO, dimethylsulfoxide; FBS, fetal bovine serum; HBSS, Hanks balanced saline solution; MOI, multiplicity of infection; NSCLC, non-small cell lung cancer; PARP, poly ADP-ribose polymerase; PI, propidiumiodide; TUNEL, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling; VACC, voltage-activated calcium channel; XTT, sodium 3,3 0 -{1-[(phenylamino)carbonyl]-3,4-tetrazolium}-bis(4-methoxy-6-nitro)-benzene sulfonic acid hydrate; wt, wild-type.
